QUESTLAB

Quest Laboratories Share Price

 

 

Start SIP in QUESTLAB

Start SIP

Performance

  • Low
  • ₹100
  • High
  • ₹105
  • 52 Week Low
  • ₹75
  • 52 Week High
  • ₹160
  • Open Price₹105
  • Previous Close₹99
  • Volume2,400
  • 50 DMA₹97.60
  • 100 DMA₹96.43
  • 200 DMA₹99.46

Investment Returns

  • Over 1 Month -4.72%
  • Over 3 Month + 17.67%
  • Over 6 Month + 6.12%
  • Over 1 Year -25.34%

Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!

Invest Now

Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.1
  • PEG Ratio
  • -
  • Market Cap Cr
  • 164
  • P/B Ratio
  • 1.8
  • Average True Range
  • 4.79
  • EPS
  • 8.63
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.15
  • RSI
  • 49.04
  • MFI
  • 39.07

Quest Laboratories Financials

Quest Laboratories Technicals

EMA & SMA

Current Price
₹100.00
+ 1.1 (1.11%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹100.01
  • 50 Day
  • ₹97.60
  • 100 Day
  • ₹96.43
  • 200 Day
  • ₹99.46

Resistance and Support

98.92 Pivot Speed
  • R3 99.13
  • R2 99.07
  • R1 98.98
  • S1 98.83
  • S2 98.77
  • S3 98.68

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Quest Laboratories Ltd has an operating revenue of Rs. 152.72 Cr. on a trailing 12-month basis. An annual revenue growth of 31% is outstanding, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its key moving averages, around 3% and 2% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 22% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 104 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Quest Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results & Others To consider other business matters.
2025-05-28 Audited Results
2025-01-27 Others To consider other business matters.
2024-11-14 Quarterly Results & Others To consider other business matters.

Quest Laboratories F&O

Quest Laboratories Shareholding Pattern

66.78%
0%
0.61%
28.36%
4.25%

About Quest Laboratories

  • NSE Symbol
  • QUESTLAB
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Anil Kumar Sabarwal
  • ISIN
  • INE0TNW01017

Similar Stocks to Quest Laboratories

Quest Laboratories FAQs

Quest Laboratories share price is ₹100 As on 01 February, 2026 | 12:13

The Market Cap of Quest Laboratories is ₹163.9 Cr As on 01 February, 2026 | 12:13

The P/E ratio of Quest Laboratories is 12.1 As on 01 February, 2026 | 12:13

The PB ratio of Quest Laboratories is 1.8 As on 01 February, 2026 | 12:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23